Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism NCLX agonists(solute carrier family 8 member B1 agonists), Na/K-ATPase agonists(Sodium/potassium-transporting ATPase agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fatigue Syndrome, Chronic | Preclinical | Germany | 01 Jul 2025 | |
Fibromyalgia | Preclinical | Germany | 01 Jul 2025 | |
Lyme Disease | Preclinical | Germany | 01 Jul 2025 | |
Persian Gulf Syndrome | Preclinical | Germany | 01 Jul 2025 |